Correlation Between Immunome and Anebulo Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Immunome and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunome and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunome and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Immunome and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunome with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunome and Anebulo Pharmaceuticals.

Diversification Opportunities for Immunome and Anebulo Pharmaceuticals

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Immunome and Anebulo is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Immunome and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Immunome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunome are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Immunome i.e., Immunome and Anebulo Pharmaceuticals go up and down completely randomly.

Pair Corralation between Immunome and Anebulo Pharmaceuticals

Given the investment horizon of 90 days Immunome is expected to generate 2.97 times less return on investment than Anebulo Pharmaceuticals. But when comparing it to its historical volatility, Immunome is 1.54 times less risky than Anebulo Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  146.00  in Anebulo Pharmaceuticals on October 23, 2024 and sell it today you would earn a total of  13.00  from holding Anebulo Pharmaceuticals or generate 8.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Immunome  vs.  Anebulo Pharmaceuticals

 Performance 
       Timeline  
Immunome 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immunome has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Anebulo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Immunome and Anebulo Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Immunome and Anebulo Pharmaceuticals

The main advantage of trading using opposite Immunome and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunome position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.
The idea behind Immunome and Anebulo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios